Dextrose and Electrolyte No 48 and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Dextrose and Electrolyte No 48 and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lvp solution with potassium
Brand name:
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextrose and Electrolyte No 48-Moxifloxacin
- Dextrose and Electrolyte No 48-Moxifloxacin (Systemic)
- Dextrose and Electrolyte No 48-Moxifloxacin Hydrochloride
- Dextrose and Electrolyte No 48-Moxifloxacin Injection
- Dextrose and Electrolyte No 48-Moxifloxacin Intravenous
- Dextrose and Electrolyte No 48-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Dextrose Chewable Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Dextrose Electrolyte No. 75
- Moxetumomab pasudotox-tdfk Intravenous-Dextrose Gel and Liquid
- Moxetumomab pasudotox-tdfk Intravenous-Dextrose Injection
- Moxetumomab pasudotox-tdfk Intravenous-Dextrose Injection 10%
- Moxetumomab pasudotox-tdfk Intravenous-Dextrose Injection 70%